Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptic gene expression modulators" refers to a large and heterogenous class of molecules—including transcription factors (such as DEAF1, MEF2), chromatin modifiers (such as CLAMP), and signaling pathway components—that regulate the transcription of genes required for synapse formation, function, and plasticity in neurons[1][2]. These modulators ensure the timely and coordinated expression of hundreds of synaptic genes during neural development and in response to neuronal activity. While they are critical for proper nervous system formation and maintenance, dysregulation of these modulators can contribute to neurodevelopmental and neuropsychiatric disorders. Importantly, "synaptic gene expression modulators" as a term refers to a functionally defined group, not a specific molecular target or druggable entity[1][2]. Key clarifying points: - The term should not be treated as a canonical drug target. - For structured drug discovery and target annotations, use individual proteins (e.g., MEF2, DEAF1, CREB) rather than broad functional descriptors. - No normalized abbreviation, specific interacting drugs, or universal biomarkers exist for this category as a whole. - For target-based research, further specify the key modulator protein of interest.
Alteration of transcriptional activity; Modulation of chromatin accessibility; Activity-dependent regulation (e.g. via calcium signaling); Epigenetic modification; Feedback regulation of synapse number
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptic gene expression modulators.